Australia markets closed

Firebrick Pharma Limited (FRE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0500-0.0010 (-1.96%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 9.13M
Enterprise value 6.77M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.45k
Price/book (mrq)3.69
Enterprise value/revenue 8.16k
Enterprise value/EBITDA -0.99

Trading information

Stock price history

Beta (5Y monthly) 1.83
52-week change 3-73.85%
S&P500 52-week change 324.01%
52-week high 30.3600
52-week low 30.0360
50-day moving average 30.0518
200-day moving average 30.1165

Share statistics

Avg vol (3-month) 3232.27k
Avg vol (10-day) 3115.23k
Shares outstanding 5178.95M
Implied shares outstanding 6178.95M
Float 895.98M
% held by insiders 146.38%
% held by institutions 10.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-29,941.77%

Management effectiveness

Return on assets (ttm)-72.06%
Return on equity (ttm)-126.49%

Income statement

Revenue (ttm)22.55k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -6.74M
Net income avi to common (ttm)-6.8M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.35M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.11
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-5.78M
Levered free cash flow (ttm)-3.2M